Scientists in a lab viewing a 3D model of Bas63 bacteriophage, illustrating breakthroughs in phage therapy research.
Scientists in a lab viewing a 3D model of Bas63 bacteriophage, illustrating breakthroughs in phage therapy research.
Picha iliyoundwa na AI

3D structure of Bas63 bacteriophage mapped, offering clues for phage therapy

Picha iliyoundwa na AI
Imethibitishwa ukweli

A University of Otago–led team, with collaborators at the Okinawa Institute of Science and Technology, has resolved the 3D structure of Bas63, a bacteriophage that infects E. coli. Published in Science Advances (online on November 12, 2025; issue dated November 14, 2025), the work details rare tail features and could inform rational phage design for medical, agricultural, and industrial uses.

Researchers have produced an in‑depth structural map of the Escherichia phage JohannRWettstein (Bas63), illuminating how its tail apparatus engages bacteria and how related viruses may have evolved. The study appears in Science Advances (DOI: 10.1126/sciadv.adx0790) and lists authors from the University of Otago and the Okinawa Institute of Science and Technology (OIST). Publication records show an online release on November 12, 2025 and an issue date of November 14, 2025. (pubmed.ncbi.nlm.nih.gov)

Lead author Dr. James Hodgkinson‑Bean described bacteriophages as “extremely exciting” alternatives to antibiotics, noting that “bacteriophage viruses are non‑harmful to all multi‑cellular life and able to very selectively target and kill a target bacterium,” which is why they are increasingly studied for phage therapy against drug‑resistant infections. Those remarks were published by the University of Otago and carried by ScienceDaily. (otago.ac.nz)

Using cryo‑electron microscopy, the team reconstructed Bas63 at molecular scale, identifying rare whisker‑and‑collar connections between the head and tail, decoration proteins at hexamer centers on the capsid, and multiple, diverse tail fibers—features that help explain how the virus recognizes and attacks its bacterial host. The OIST news release and the paper’s abstract highlight these elements, including β‑tulip and Hoc‑like decoration proteins, as well as long tail fibers resembling those in phage T4. (oist.jp)

Senior author Associate Professor Mihnea Bostina said the “detailed blueprint of a bacteriophage” can advance rational design for applications ranging from treating infections to combating biofilms in food processing and water systems, a comment echoed in Otago’s newsroom announcement. The researchers also frame the work amid rising antibiotic resistance and threats to global food security from plant pathogens. (otago.ac.nz)

The authors further argue that structural comparisons reveal distant evolutionary links, including relationships between bacteriophages and herpes viruses that may trace back billions of years—a perspective Hodgkinson‑Bean articulated in the university release. The underlying journal article focuses on structural conservation within the Felixounavirus genus and does not date those links, so the time‑scale characterization is presented here as the researchers’ interpretation. (otago.ac.nz)

This is the group’s second full phage structure in 2025: in April, members of the same Otago–OIST team reported the atomic‑level architecture of the potato‑pathogen‑targeting phage φTE in Nature Communications, work they say provides a template for designing biocontrol agents in agriculture. (pmc.ncbi.nlm.nih.gov)

Watu wanasema nini

Discussions on X about the 3D structure mapping of Bas63 bacteriophage are predominantly positive, emphasizing its potential to advance phage therapy against antibiotic-resistant bacteria. Researchers and science accounts highlight evolutionary insights and applications in medicine, agriculture, and industry. Shares from academic labs and enthusiasts express excitement over the structural details revealed by cryo-EM. No negative or skeptical sentiments were identified in recent posts.

Makala yanayohusiana

Microscopic view of bacterial cell with biomolecular condensates featuring internal protein filament scaffolds, illustrating new research findings.
Picha iliyoundwa na AI

Study finds filament “skeleton” inside bacterial biomolecular condensates, suggesting new therapeutic angles

Imeripotiwa na AI Picha iliyoundwa na AI Imethibitishwa ukweli

Scientists at Scripps Research report that some biomolecular condensates—membrane-less, droplet-like cellular compartments—contain networks of thin protein filaments that act as an internal scaffold. The team says disrupting this filament architecture alters condensate physical properties and impairs bacterial growth and DNA segregation, raising the possibility that condensate structure could one day be therapeutically targetable in diseases such as cancer and ALS. The study appeared in Nature Structural & Molecular Biology on February 2, 2026.

Scientists in Japan have discovered a giant virus called ushikuvirus that infects amoebae and provides evidence for the theory that viruses contributed to the evolution of complex cells. Isolated from Lake Ushiku, the virus exhibits unique structural and replication traits linking it to other giant DNA viruses. This finding, published in the Journal of Virology, deepens understanding of viral roles in eukaryotic evolution.

Imeripotiwa na AI

Researchers at Caltech have discovered how viruses infect bacteria by disabling a key protein called MurJ, essential for cell wall construction. This mechanism, revealed through high-resolution imaging, suggests a new approach to combating antibiotic-resistant superbugs. The findings highlight convergent evolution in unrelated viruses blocking MurJ similarly.

Researchers at the University of California San Diego report they have developed a second-generation CRISPR-based “Pro-Active Genetics” system, called pPro-MobV, that is designed to spread between bacteria and disable antibiotic-resistance genes, including inside hard-to-treat biofilms.

Imeripotiwa na AI Imethibitishwa ukweli

Researchers at Harvard’s Wyss Institute and Dana-Farber Cancer Institute report that a DNA origami-based vaccine platform called DoriVac generated robust immune responses in mice and in a human lymph node “Organ Chip” model. The team says the approach could be easier to store and manufacture than lipid nanoparticle–delivered mRNA vaccines, though the work remains preclinical. The results were published in Nature Biomedical Engineering.

Scientists at the University of Southern Denmark and Odense University Hospital have identified a previously unknown virus inside the common gut bacterium Bacteroides fragilis that appears more frequently in people with colorectal cancer. The finding, detailed by lead researcher Flemming Damgaard, resolves a long-standing paradox since the bacterium is also present in healthy individuals. While the link is strong, the virus's role in causing cancer remains unproven.

Imeripotiwa na AI

Researchers at Fred Hutch Cancer Center have created human-like monoclonal antibodies that prevent Epstein-Barr virus (EBV) from infecting immune cells. Using mice engineered with human antibody genes, the team identified antibodies targeting viral proteins gp350 and gp42, with one fully blocking infection in lab models. The findings, published in Cell Reports Medicine, could lead to therapies for transplant patients at risk of EBV-related complications.

Tovuti hii inatumia vidakuzi

Tunatumia vidakuzi kwa uchambuzi ili kuboresha tovuti yetu. Soma sera ya faragha yetu kwa maelezo zaidi.
Kataa